Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin, Quercetin and Vitamin D3 for Mild to Moderate COVID-19
NCT04603690Completed
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Aug 2021
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Liaquat University of Medical and Health Sciences. Primary endpoints: SARS-CoV-2 Negativity by RT-PCR at 14 days and COVID-19 symptoms improvement at 7 days. Started Aug 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04603690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603690.